期刊文献+

138株临床分离肺炎克雷伯菌耐药性与多位点序列分型研究 被引量:2

Antibiotic resistance and multilocus sequence typing research of 138 strains isolated klebsiella pneumoniae
下载PDF
导出
摘要 目的:研究肺炎克雷伯菌的耐药率与分子流行病学规律,明确其遗传背景,为临床抗菌药物的合理选择提供依据。方法收集临床分离肺炎克雷伯菌138株,采用K-B纸片扩散法进行10种常用抗菌药物的体外药物敏感性试验,对所有菌株进行多位点序列分型(MLST)。结果 MLST方案中选取的7个管家基因GC含量均分布于55.02%~65.06%。各等位基因数分布于3~6范围内,其中infB的等位基因数只有3个,而tonB的等位基因数有6个。tonB的多态性位点最多,为79个;体外药物敏感性试验结果表明,138株肺炎克雷伯菌对10种抗菌药物耐药率分布于9.42%~50.00%;MLST结果显示,全部菌株共形成9个ST型,其中ST11有78株、ST258有16株、ST340有10株、ST379有8株,上述4个ST型均属于克隆复合体CC258。此外,本次研究还发现1个新ST型。结论肺炎克雷伯菌对临床常用抗菌药物的耐药率较高,呈现多重耐药趋势;肺炎克雷伯菌的传播趋势相对集中,在院内抗生素选择压的作用下易形成典型的克隆复合体。 Objective To research the resistant rate and molecular epidemiology of Klebsiella pneumonia and clarify the genetic backgrounds, thus to provide basis for clinical use of antibiotics. Methods A total of 138 strains isolated Kleb-siella pneumoniae were collected to detect antibiotics susceptibility testing by K-B disk diffusion and multilocus sequence typing (MLST). The eBURST and START2 software were used to analyze MLST data. Results The GC content of seven housekeeping genes included in MLST scheme were from 55.02%to 65.06%. The number of alleles was range from three to six. The infB only had three alleles while six in tonB. tonB possessed the most polymorphism sites which had seventy-nine. The antibiotics susceptibility testing showed that the resistant rate of 138 strains isolated Klebsiella pneumoniae to ten an-tibiotics were from 9.42%to 50.00%. MLST research indicated that all isolates clustered into 9 ST types, of which were 78 strains in ST11, 16 strains in ST258, 10 strains in ST340, 8 strains in ST379. They were all clustered into one clonal complex CC258. Moreover, there was one novel ST observed in this study. Conclusion The resistant rates of Klebsiella pneumoniae to clinical antimicrobial are relatively high, and emerging multiple-drug resistance tendency. Besides, the dis-semination pattern of Klebsiella pneumoniae is relatively concentrated and could form a typical clone complex easily under the nosocomial antibiotic selection pressure.
出处 《全科医学临床与教育》 2015年第5期529-532,共4页 Clinical Education of General Practice
关键词 肺炎克雷伯菌 多位点序列分型 管家基因 克隆复合体 klebsiella pneumoniae MLST housekeeping gene clonal complex
  • 相关文献

参考文献7

  • 1Nordmann P, Cuzon G, Naas T. The real threat of klebsiellapneumoniae carbapenemase -producing bacteria [J]. LancetInfect Dis, 2009, 9(4): 228-236.
  • 2汪复,朱德妹,胡付品,蒋晓飞,胡志东,李全,孙自镛,陈中举,徐英春,张小江,王传清,王爱敏,倪语星,孙景勇,褚云卓,俞云松,林洁,徐元宏,沈继录,苏丹虹,卓超,魏莲花,吴玲,张朝霞,季萍,张泓,孔菁,胡云建,艾效曼,单斌,杜艳.2012年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2013,13(5):321-330. 被引量:465
  • 3Maiden CJ. Multilocus sequence typing of bacteria[J]. AnnuRev Microbiol,2006,60(1):561.
  • 4Diancourt L, Passet V, Verhoef J, et al. Multilocus sequencetyping of klebsiella pneumoniae nosocomial isolates[J]. J ClinMicrobiol, 2005, 43(8): 4178-4182.
  • 5Jolley KA, Feil EJ, Chan MS, et al. Sequence type analy-sis and recombinational tests (START) [J]. Bioinformatics,2001, 17(12): 1230-1231.
  • 6Munoz -Price LS, Poirel L, Bonomo RA, et al. Clinicalepidemiology of the global expansion of klebsiella pneumo-niae carbapenemases[J]. Lancet Infect Dis, 2013, 13(9):785-796.
  • 7Petrosillo N, Giannella M, Lewis R, et al. Treatment ofcarbapenem -resistant klebsiella pneumoniae : the state ofthe art[J]. Expert Rev Anti-infe, 2013,11(2): 159-177.

二级参考文献21

  • 1CLSI Performance standards for antimicrobial susceptibility testing[S]. Twenty second Informational supplement M100- S22 2012,32(3).
  • 2European Committee on Antimicrobial susceptibility testing, Breakpoint tables for interpretation of MICs and zone diame- ters[S]. Version 2, 2012, valid from 2012-01-01.
  • 3Bush K. Alarming β-lactamase mediated resistance in multi- drug-resistant Enterobacteraceae[J]. Curr Opinion Microbi- oh 2010, 13(5): 558-564.
  • 4Nordmann P, Dortet L, Poirel L. Carbepenem resistance in Enterobacteriaceae: here is the storm! [J]. Trends Mol Med, 2012, 18(6): 263-271.
  • 5Hu FP, Chen SD, Xu XG, et al. Emergence of carbapenem resistant clinical Enterobacteriaceae isolates from a teaching hospital in Shanghai, China[J]. J Med Microbiol, 2012,61 (Ptl) : 132-136.
  • 6Yang Q, Wang H, Sun H, et al. Phenotypic and genotypic characterization of Enterobacteriaceae with decreased suseep tibility to carbapenems: results from large hospital-based sur veillance studies in China[J]. Antimicrob Agents Chemoth er, 2010, 54(1):573-577.
  • 7Chen SD, Hu FP, Xu XG, et al. High prevalence of KPC-2 carbapenemase coupled with CTX-M-type extended-spectrum 13-1actamase in carbapenem-resistant Klebsiella pneumoniae in a teaching hospital in China[J]. Antimierob Agents Che- mother, 2011, 55(5) :2493-2444.
  • 8Hawser SP, Bouchillon SK, Lascols C, et al. Susceptibility of Klebsiella pneumoniae isolates from intra-abdominal infec- tions and molecular characterization of ertapenem-resistant i- solates[J]. Antimicrob Agents Chemother, 2011, 55 (8) : 3917-3921.
  • 9Lascols C, Peirano G, Hackel M, et al. Surveillance and mo- lecular epidemiology of Klebsiella pneumoniae isolates that produce Carbapenemase:first report of OXA-48-1ike enzymes in north America[J]. Antimicrob Agents Chemother, 2013, 57(1):130-136.
  • 10Porton A, Nordmann P, Poirel L. Characterization of OXA-204, a carbapenem hydrolyzing class D 17 lactamase from Klebsiella pneumoniae [J]. Antimicrob Agents Chemother, 2013, 57(1) :633-636.

共引文献464

同被引文献23

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部